Global Nucleic Acid–Based Diagnostic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 49167
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Nucleic Acid–Based Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nucleic Acid–Based Diagnostic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Nucleic Acid–Based Diagnostic market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Nucleic Acid–Based Diagnostic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Nucleic Acid Molecular Hybridization

Polymerase Chain Reaction

Thermostatic Amplification

Gene Sequencing

Biochip Technology

Market segment by Application, can be divided into

Hospital

Clinical Laboratory

Research Institutions

Clinic

Other

Market segment by players, this report covers

Agilent Technologies

Danaher Corporation

Abbott Laboratories

BD

Bio-Rad Laboratories

Roche

Illumina, Inc

Thermo Fisher Scientific Inc.

Merck KGaA

Qiagen

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Nucleic Acid–Based Diagnostic

1.2 Classification of Nucleic Acid–Based Diagnostic by Type

1.2.1 Overview: Global Nucleic Acid–Based Diagnostic Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type in 2020

1.2.3 Nucleic Acid Molecular Hybridization

1.2.4 Polymerase Chain Reaction

1.2.5 Thermostatic Amplification

1.2.6 Gene Sequencing

1.2.7 Biochip Technology

1.3 Global Nucleic Acid–Based Diagnostic Market by Application

1.3.1 Overview: Global Nucleic Acid–Based Diagnostic Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinical Laboratory

1.3.4 Research Institutions

1.3.5 Clinic

1.3.6 Other

1.4 Global Nucleic Acid–Based Diagnostic Market Size & Forecast

1.5 Global Nucleic Acid–Based Diagnostic Market Size and Forecast by Region

1.5.1 Global Nucleic Acid–Based Diagnostic Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Nucleic Acid–Based Diagnostic Market Size by Region, (2016-2021)

1.5.3 North America Nucleic Acid–Based Diagnostic Market Size and Prospect (2016-2026)

1.5.4 Europe Nucleic Acid–Based Diagnostic Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size and Prospect (2016-2026)

1.5.6 South America Nucleic Acid–Based Diagnostic Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Nucleic Acid–Based Diagnostic Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Nucleic Acid–Based Diagnostic Market Drivers

1.6.2 Nucleic Acid–Based Diagnostic Market Restraints

1.6.3 Nucleic Acid–Based Diagnostic Trends Analysis

2 Company Profiles

2.1 Agilent Technologies

2.1.1 Agilent Technologies Details

2.1.2 Agilent Technologies Major Business

2.1.3 Agilent Technologies Nucleic Acid–Based Diagnostic Product and Solutions

2.1.4 Agilent Technologies Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Agilent Technologies Recent Developments and Future Plans

2.2 Danaher Corporation

2.2.1 Danaher Corporation Details

2.2.2 Danaher Corporation Major Business

2.2.3 Danaher Corporation Nucleic Acid–Based Diagnostic Product and Solutions

2.2.4 Danaher Corporation Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Danaher Corporation Recent Developments and Future Plans

2.3 Abbott Laboratories

2.3.1 Abbott Laboratories Details

2.3.2 Abbott Laboratories Major Business

2.3.3 Abbott Laboratories Nucleic Acid–Based Diagnostic Product and Solutions

2.3.4 Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Abbott Laboratories Recent Developments and Future Plans

2.4 BD

2.4.1 BD Details

2.4.2 BD Major Business

2.4.3 BD Nucleic Acid–Based Diagnostic Product and Solutions

2.4.4 BD Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 BD Recent Developments and Future Plans

2.5 Bio-Rad Laboratories

2.5.1 Bio-Rad Laboratories Details

2.5.2 Bio-Rad Laboratories Major Business

2.5.3 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product and Solutions

2.5.4 Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.6 Roche

2.6.1 Roche Details

2.6.2 Roche Major Business

2.6.3 Roche Nucleic Acid–Based Diagnostic Product and Solutions

2.6.4 Roche Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Roche Recent Developments and Future Plans

2.7 Illumina, Inc

2.7.1 Illumina, Inc Details

2.7.2 Illumina, Inc Major Business

2.7.3 Illumina, Inc Nucleic Acid–Based Diagnostic Product and Solutions

2.7.4 Illumina, Inc Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Illumina, Inc Recent Developments and Future Plans

2.8 Thermo Fisher Scientific Inc.

2.8.1 Thermo Fisher Scientific Inc. Details

2.8.2 Thermo Fisher Scientific Inc. Major Business

2.8.3 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product and Solutions

2.8.4 Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans

2.9 Merck KGaA

2.9.1 Merck KGaA Details

2.9.2 Merck KGaA Major Business

2.9.3 Merck KGaA Nucleic Acid–Based Diagnostic Product and Solutions

2.9.4 Merck KGaA Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Merck KGaA Recent Developments and Future Plans

2.10 Qiagen

2.10.1 Qiagen Details

2.10.2 Qiagen Major Business

2.10.3 Qiagen Nucleic Acid–Based Diagnostic Product and Solutions

2.10.4 Qiagen Nucleic Acid–Based Diagnostic Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Qiagen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nucleic Acid–Based Diagnostic Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Nucleic Acid–Based Diagnostic Players Market Share

3.2.2 Top 10 Nucleic Acid–Based Diagnostic Players Market Share

3.2.3 Market Competition Trend

3.3 Nucleic Acid–Based Diagnostic Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Nucleic Acid–Based Diagnostic Revenue and Market Share by Type (2016-2021)

4.2 Global Nucleic Acid–Based Diagnostic Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Nucleic Acid–Based Diagnostic Revenue Market Share by Application (2016-2021)

5.2 Nucleic Acid–Based Diagnostic Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Nucleic Acid–Based Diagnostic Revenue by Type (2016-2026)

6.2 North America Nucleic Acid–Based Diagnostic Revenue by Application (2016-2026)

6.3 North America Nucleic Acid–Based Diagnostic Market Size by Country

6.3.1 North America Nucleic Acid–Based Diagnostic Revenue by Country (2016-2026)

6.3.2 United States Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

6.3.3 Canada Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

6.3.4 Mexico Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Nucleic Acid–Based Diagnostic Revenue by Type (2016-2026)

7.2 Europe Nucleic Acid–Based Diagnostic Revenue by Application (2016-2026)

7.3 Europe Nucleic Acid–Based Diagnostic Market Size by Country

7.3.1 Europe Nucleic Acid–Based Diagnostic Revenue by Country (2016-2026)

7.3.2 Germany Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

7.3.3 France Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

7.3.5 Russia Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

7.3.6 Italy Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Type (2016-2026)

8.2 Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Application (2016-2026)

8.3 Asia-Pacific Nucleic Acid–Based Diagnostic Market Size by Region

8.3.1 Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Region (2016-2026)

8.3.2 China Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

8.3.3 Japan Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

8.3.4 South Korea Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

8.3.5 India Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

8.3.7 Australia Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Nucleic Acid–Based Diagnostic Revenue by Type (2016-2026)

9.2 South America Nucleic Acid–Based Diagnostic Revenue by Application (2016-2026)

9.3 South America Nucleic Acid–Based Diagnostic Market Size by Country

9.3.1 South America Nucleic Acid–Based Diagnostic Revenue by Country (2016-2026)

9.3.2 Brazil Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

9.3.3 Argentina Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Type (2016-2026)

10.2 Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Application (2016-2026)

10.3 Middle East & Africa Nucleic Acid–Based Diagnostic Market Size by Country

10.3.1 Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Country (2016-2026)

10.3.2 Turkey Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

10.3.4 UAE Nucleic Acid–Based Diagnostic Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Nucleic Acid–Based Diagnostic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Nucleic Acid–Based Diagnostic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Nucleic Acid–Based Diagnostic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Nucleic Acid–Based Diagnostic Revenue (USD Million) by Region (2016-2021)

Table 5. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Region (2021-2026)

Table 6. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 7. Agilent Technologies Major Business

Table 8. Agilent Technologies Nucleic Acid–Based Diagnostic Product and Solutions

Table 9. Agilent Technologies Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 11. Danaher Corporation Major Business

Table 12. Danaher Corporation Nucleic Acid–Based Diagnostic Product and Solutions

Table 13. Danaher Corporation Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 15. Abbott Laboratories Major Business

Table 16. Abbott Laboratories Nucleic Acid–Based Diagnostic Product and Solutions

Table 17. Abbott Laboratories Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. BD Corporate Information, Head Office, and Major Competitors

Table 19. BD Major Business

Table 20. BD Nucleic Acid–Based Diagnostic Product and Solutions

Table 21. BD Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 23. Bio-Rad Laboratories Major Business

Table 24. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Product and Solutions

Table 25. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Roche Corporate Information, Head Office, and Major Competitors

Table 27. Roche Major Business

Table 28. Roche Nucleic Acid–Based Diagnostic Product and Solutions

Table 29. Roche Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Illumina, Inc Corporate Information, Head Office, and Major Competitors

Table 31. Illumina, Inc Major Business

Table 32. Illumina, Inc Nucleic Acid–Based Diagnostic Product and Solutions

Table 33. Illumina, Inc Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors

Table 35. Thermo Fisher Scientific Inc. Major Business

Table 36. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Product and Solutions

Table 37. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 39. Merck KGaA Major Business

Table 40. Merck KGaA Nucleic Acid–Based Diagnostic Product and Solutions

Table 41. Merck KGaA Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Qiagen Corporate Information, Head Office, and Major Competitors

Table 43. Qiagen Major Business

Table 44. Qiagen Nucleic Acid–Based Diagnostic Product and Solutions

Table 45. Qiagen Nucleic Acid–Based Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Nucleic Acid–Based Diagnostic Revenue (USD Million) by Players (2019-2021)

Table 47. Global Nucleic Acid–Based Diagnostic Revenue Share by Players (2019-2021)

Table 48. Breakdown of Nucleic Acid–Based Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Nucleic Acid–Based Diagnostic Players Head Office, Products and Services Provided

Table 50. Nucleic Acid–Based Diagnostic Mergers & Acquisitions in the Past Five Years

Table 51. Nucleic Acid–Based Diagnostic New Entrants and Expansion Plans

Table 52. Global Nucleic Acid–Based Diagnostic Revenue (USD Million) by Type (2016-2021)

Table 53. Global Nucleic Acid–Based Diagnostic Revenue Share by Type (2016-2021)

Table 54. Global Nucleic Acid–Based Diagnostic Revenue Forecast by Type (2021-2026)

Table 55. Global Nucleic Acid–Based Diagnostic Revenue by Application (2016-2021)

Table 56. Global Nucleic Acid–Based Diagnostic Revenue Forecast by Application (2021-2026)

Table 57. North America Nucleic Acid–Based Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Nucleic Acid–Based Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Nucleic Acid–Based Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Nucleic Acid–Based Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Nucleic Acid–Based Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Nucleic Acid–Based Diagnostic Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Nucleic Acid–Based Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Nucleic Acid–Based Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Nucleic Acid–Based Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Nucleic Acid–Based Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Nucleic Acid–Based Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Nucleic Acid–Based Diagnostic Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Nucleic Acid–Based Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Nucleic Acid–Based Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Nucleic Acid–Based Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Nucleic Acid–Based Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Nucleic Acid–Based Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Nucleic Acid–Based Diagnostic Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Nucleic Acid–Based Diagnostic Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Nucleic Acid–Based Diagnostic Picture

Figure 2. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Type in 2020

Figure 3. Nucleic Acid Molecular Hybridization

Figure 4. Polymerase Chain Reaction

Figure 5. Thermostatic Amplification

Figure 6. Gene Sequencing

Figure 7. Biochip Technology

Figure 8. Nucleic Acid–Based Diagnostic Revenue Market Share by Application in 2020

Figure 9. Hospital Picture

Figure 10. Clinical Laboratory Picture

Figure 11. Research Institutions Picture

Figure 12. Clinic Picture

Figure 13. Other Picture

Figure 14. Global Nucleic Acid–Based Diagnostic Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Nucleic Acid–Based Diagnostic Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Region (2016-2026)

Figure 17. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Region in 2020

Figure 18. North America Nucleic Acid–Based Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Nucleic Acid–Based Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Nucleic Acid–Based Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Nucleic Acid–Based Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Nucleic Acid–Based Diagnostic Market Drivers

Figure 24. Nucleic Acid–Based Diagnostic Market Restraints

Figure 25. Nucleic Acid–Based Diagnostic Market Trends

Figure 26. Agilent Technologies Recent Developments and Future Plans

Figure 27. Danaher Corporation Recent Developments and Future Plans

Figure 28. Abbott Laboratories Recent Developments and Future Plans

Figure 29. BD Recent Developments and Future Plans

Figure 30. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 31. Roche Recent Developments and Future Plans

Figure 32. Illumina, Inc Recent Developments and Future Plans

Figure 33. Thermo Fisher Scientific Inc. Recent Developments and Future Plans

Figure 34. Merck KGaA Recent Developments and Future Plans

Figure 35. Qiagen Recent Developments and Future Plans

Figure 36. Global Nucleic Acid–Based Diagnostic Revenue Share by Players in 2020

Figure 37. Nucleic Acid–Based Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Nucleic Acid–Based Diagnostic Revenue Market Share in 2020

Figure 39. Global Top 10 Players Nucleic Acid–Based Diagnostic Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Nucleic Acid–Based Diagnostic Revenue Share by Type in 2020

Figure 42. Global Nucleic Acid–Based Diagnostic Market Share Forecast by Type (2021-2026)

Figure 43. Global Nucleic Acid–Based Diagnostic Revenue Share by Application in 2020

Figure 44. Global Nucleic Acid–Based Diagnostic Market Share Forecast by Application (2021-2026)

Figure 45. North America Nucleic Acid–Based Diagnostic Sales Market Share by Type (2016-2026)

Figure 46. North America Nucleic Acid–Based Diagnostic Sales Market Share by Application (2016-2026)

Figure 47. North America Nucleic Acid–Based Diagnostic Revenue Market Share by Country (2016-2026)

Figure 48. United States Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Nucleic Acid–Based Diagnostic Sales Market Share by Type (2016-2026)

Figure 52. Europe Nucleic Acid–Based Diagnostic Sales Market Share by Application (2016-2026)

Figure 53. Europe Nucleic Acid–Based Diagnostic Revenue Market Share by Country (2016-2026)

Figure 54. Germany Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Nucleic Acid–Based Diagnostic Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Nucleic Acid–Based Diagnostic Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Nucleic Acid–Based Diagnostic Revenue Market Share by Region (2016-2026)

Figure 62. China Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Nucleic Acid–Based Diagnostic Sales Market Share by Type (2016-2026)

Figure 69. South America Nucleic Acid–Based Diagnostic Sales Market Share by Application (2016-2026)

Figure 70. South America Nucleic Acid–Based Diagnostic Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Nucleic Acid–Based Diagnostic Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Nucleic Acid–Based Diagnostic Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Nucleic Acid–Based Diagnostic Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Nucleic Acid–Based Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz